Home / Import refusals / NUV-3881703-0/100002/1

FDA Import Refusal NUV-3881703-0/100002/1 — Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited — FEI 3002808311

The FDA refused shipment NUV-3881703-0/100002/1 from Takeda Pharmaceutical Company Limited (Japan) on February 24, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 118 This firm has 5 or more other import refusals on record.

Refusal Details

Date
February 24, 2026
Country
Japan
Product Category
Drugs and Biologics
Product Code
61PCP72 SEMAGLUTIDE (ANTI-DIABETIC)
Charges
118

Recent inspections

  • 1238763 (NAI Fri Apr 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1100693 (VAI Fri Aug 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1028828 (NAI Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 943082 (VAI Fri Sep 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 853928 (VAI Fri Sep 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • NUV-3881703-0/80002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7622704-2/12/1 (Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-4270100-7/11/1 (Fri Jun 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-3879562-5/191/1 (Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-4975019-3/11/1 (Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources